Modalis Therapeutics Corporation (TYO:4883)
Japan · Delayed Price · Currency is JPY 90.00
+2.00 (2.27%)
Jul 17, 2025, 3:30 PM JST
Modalis Therapeutics Market Cap
Modalis Therapeutics has a market cap or net worth of 6.92 billion as of July 17, 2025. Its market cap has increased by 172.70% in one year.
Market Cap
6.92B
Enterprise Value
3.36B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
90.00
Market Cap Chart
Since August 3, 2020, Modalis Therapeutics's market cap has decreased from 60.66B to 6.92B, a decrease of -88.59%. That is a compound annual growth rate of -35.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2025 | 6.77B | -4.37% |
| Dec 30, 2024 | 7.08B | 80.79% |
| Dec 29, 2023 | 3.92B | -59.92% |
| Dec 30, 2022 | 9.77B | -44.97% |
| Dec 30, 2021 | 17.75B | -71.83% |
| Dec 30, 2020 | 63.03B | 3.92% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 11.39T |
| Takeda Pharmaceutical Company | 6,967.03B |
| Daiichi Sankyo Company | 6,484.75B |
| HOYA Corporation | 6,229.63B |
| Terumo | 3,609.21B |
| Otsuka Holdings | 3,478.27B |
| Astellas Pharma | 2,599.53B |
| Shionogi & | 2,139.90B |